Now in its 13th year, the Neurotech Investing & Partnering Conference is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients.
Organized by the Neurotechnology Industry Organization and Cambridge Innovation Institute, the 13th annual conference will be held May 1-2, 2018 at the Renaissance Waterfront Hotel in Boston, MA.
The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.
This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.
We are happy to report that we have rescheduled the PSG Annual Meeting & Symposium for Friday, May 4-Sunday, May 6, 2018 at the Hyatt Regency Hotel in Jersey City, NJ. We are partnering with the Parkinson’s Foundation during their Center Leadership Conference. Agenda planning is in preliminary stages. Please check back here soon for more complete details.
Our opening reception on Friday, May 4, will be followed by the first meeting with our Symposium on Saturday, May 5, at 8:00 a.m. The PSG annual meeting with the PSG General Session with take place that afternoon. Activities on Sunday, May 6, will start at 8:00 a.m. with more study-specific meetings and working group meetings. Events will wrap up by 2:00 p.m. on Sunday.
Registration and lodging will open after the formal invitations go out.
We sincerely hope you can attend.
Dear Colleagues and Friends,
We cordially invite you to join us for the 10th International Symposium on Neuroprotection and Neurorepair (ISN&N), which will take place from October 09 to October 11, 2018.
The anniversary ISN&N meeting will take place in the vineyards of Radebeul, a quaint town at the gates of the baroque City of Dresden. Dresden has been the residence of the Saxon kings for centuries, and has a strong and rich cultural and academic history. Situated at the banks of the Elbe river, Dresden is considered one of Germany’s nicest and prosperous cities.
In continuation of the successful past meetings with up to 400 participants, the scientific focus of the 10th ISN&N will be on cerebral ischemia and brain hemorrhage, neurotrauma, neurodegeneration as well as related disciplines. Together, we will learn about and discuss the most recent and exciting findings from fundamental and translational neuroscience, as well as diagnostic and therapeutic developments.
The 10th ISN&N will provide a strong platform for contributions from the audience. Minisymposia organized by participants and ample oral presentation from delegates will accompany the key note presentations by outstanding international speakers. The 10th ISN&N will also feature ample time for discussions and scientific exchange.
We are currently setting up an exciting program for you, which will soon become available online!
Please regularly browse our homepage or join our newsletter to learn about the latest and updates. We do look forward to welcome you in Leipzig!
With warmest regards,
Johannes Boltze, MD, PhD
Chair of the Organizational Committee
Come join us to the joint global neurofibromatosis conference in Paris, from the 2nd to 6th November 2018 at the Maison de la Chimie in Paris! This conference will combine the 18th European Neurofibromatosis Meeting, the 2018 NF Conference and the 2018 Schwannomatosis & NF2 State of the Art. 800 researchers, clinicians and physicians from all the world are expected to share their knowledge about neurofibromatosis diseases.
A rich scientific program: The conference will feature the following keynote speakers:
EUMS Accreditation: The conference organizers will be seeking approval from the European Association Council for Continuing Medical Education in Brussels (EACCME), an institution of the UEMS, to provide EACCME credits for the attendance at the scientific sessions.
EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). Details will be available on the meeting website as soon as possible.